Stratos Wealth Partners, Ltd. Amgen Inc Transaction History

Stratos Wealth Partners, Ltd.

$6.79 Billion
Q3 2024

A detailed history of Stratos Wealth Partners, Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 29,029 shares of AMGN stock, worth $9.17 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

29,029

Previous 25,371 14.42%

Holding current value

$9.17 Million

Previous $7.93 Million 17.99%

% of portfolio

0.14%

Previous 0.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$309.38 - $337.38 $1.13 Million - $1.23 Million	3,658 Added 14.42%	29,029 $9.35 Million
Q2 2024 Jul 24, 2024	BUY	$262.75 - $319.31 $34,945 - $42,468	133 Added 0.53%	25,371 $7.93 Million
Q1 2024 Apr 16, 2024	BUY	$268.87 - $324.56 $87,651 - $105,806	326 Added 1.31%	25,238 $7.18 Million
Q4 2023 Jan 24, 2024	BUY	$255.7 - $288.46 $241,892 - $272,883	946 Added 3.95%	24,912 $7.18 Million
Q3 2023 Oct 24, 2023	BUY	$218.65 - $271.46 $885,532 - $1.1 Million	4,050 Added 20.34%	23,966 $6.44 Million
Q2 2023 Jul 18, 2023	BUY	$214.27 - $253.37 $399,399 - $472,281	1,864 Added 10.33%	19,916 $4.42 Million
Q1 2023 Apr 27, 2023	SELL	$225.79 - $275.2 $400,099 - $487,654	-1,772 Reduced 8.94%	18,052 $4.36 Million
Q4 2022 Jan 19, 2023	BUY	$229.03 - $291.01 $210,478 - $267,438	919 Added 4.86%	19,824 $0
Q3 2022 Oct 24, 2022	SELL	$224.46 - $253.15 $133,778 - $150,877	-596 Reduced 3.06%	18,905 $4.26 Million
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $101,050 - $112,452	-438 Reduced 2.2%	19,501 $4.75 Million
Q1 2022 Apr 26, 2022	SELL	$219.27 - $242.57 $2.56 Million - $2.84 Million	-11,689 Reduced 36.96%	19,939 $4.82 Million
Q4 2021 Jan 14, 2022	SELL	$198.88 - $227.6 $50,913 - $58,265	-256 Reduced 0.8%	31,628 $7.12 Million
Q3 2021 Oct 19, 2021	SELL	$212.27 - $248.7 $161,749 - $189,509	-762 Reduced 2.33%	31,884 $6.78 Million
Q2 2021 Jul 19, 2021	BUY	$233.58 - $259.14 $129,870 - $144,081	556 Added 1.73%	32,646 $7.96 Million
Q1 2021 Apr 27, 2021	BUY	$221.91 - $258.6 $17,308 - $20,170	78 Added 0.24%	32,090 $7.98 Million
Q4 2020 Jan 29, 2021	SELL	$216.38 - $257.67 $135,453 - $161,301	-626 Reduced 1.92%	32,012 $7.36 Million
Q3 2020 Oct 29, 2020	SELL	$234.65 - $260.95 $26,515 - $29,487	-113 Reduced 0.35%	32,638 $8.3 Million
Q2 2020 Jul 28, 2020	BUY	$197.81 - $242.74 $307,990 - $377,946	1,557 Added 4.99%	32,751 $7.73 Million
Q1 2020 May 04, 2020	BUY	$182.24 - $241.7 $937,989 - $1.24 Million	5,147 Added 19.76%	31,194 $6.32 Million
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $51,843 - $66,636	274 Added 1.06%	26,047 $6.28 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $4.44 Million - $5.32 Million	25,483 Added 8787.24%	25,773 $4.99 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $4.43 Million - $5.31 Million	-25,467 Reduced 98.87%	290 $5.29 Million
Q2 2019 Aug 06, 2019	BUY	$166.7 - $195.41 $87,017 - $102,004	522 Added 2.07%	25,757 $4.75 Million
Q1 2019 May 07, 2019	BUY	$180.87 - $203.88 $11,033 - $12,436	61 Added 0.24%	25,235 $4.79 Million
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $4.49 Million - $5.24 Million	25,174 New	25,174 $4.9 Million
Q3 2018 Nov 02, 2018	SELL	$185.29 - $208.89 $4.77 Million - $5.38 Million	-25,746 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $320,310 - $359,777	-1,929 Reduced 6.97%	25,746 $4.75 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $3.91 Million - $4.56 Million	-23,049 Reduced 45.44%	27,675 $4.72 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $614,226 - $686,279	-3,639 Reduced 6.69%	50,724 $8.82 Million
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $9.09 Million - $10.4 Million	54,363	54,363 $10.1 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.29M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Account

Stratos Wealth Partners, Ltd. Amgen Inc Transaction History